Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study on the Safety of Tirbanibulin and Diclofenac Sodium for Adults with Actinic Keratosis on the Face or Scalp

    Not recruiting

    1 1 1 1
    Investigated diseases:
    France Germany Italy Poland Spain
  • Study Comparing Romiplostim and Dexamethasone with Dexamethasone Alone for Patients with Newly Diagnosed Primary Immune Thrombocytopenia

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Italy Spain
  • Study of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer

    Not recruiting

    1 1 1 1
    Austria Belgium France Germany Hungary Ireland +4
  • Study on Golcadomide and R-CHOP Drug Combination for Patients with Untreated High-risk Large B-cell Lymphoma

    Not recruiting

    1 1 1
    Austria Bulgaria Czechia Denmark Finland France +11
  • Study on Batoclimab for Patients with Thyroid Eye Disease

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Hungary Italy Latvia Poland Slovakia +1
  • Study of Futibatinib and Pembrolizumab for Patients with Advanced or Metastatic Bladder, Urethra, or Pelvis Cancer Not Suitable for Platinum Treatment

    Not recruiting

    1 1 1
    Investigated drugs:
    France
  • Study on the Effectiveness and Safety of Ranibizumab for Patients with Wet Age-Related Macular Degeneration Using a 36-Week Refill System

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium France Germany Italy Spain
  • Study on Long-Term Safety of GSK1070806 for Patients with Moderate to Severe Atopic Dermatitis

    Not recruiting

    Investigated diseases:
    Bulgaria Czechia France Germany Greece Italy +2
  • Study on the Safety and Effectiveness of Zilucoplan Auto-Injector for Adults with Generalized Myasthenia Gravis

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Poland
  • Study of Vorasidenib for Patients with Residual or Recurrent Grade 2 Glioma with IDH1 or IDH2 Mutation

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy The Netherlands Spain